JUN 16, 2021 6:00 AM PDT

Rapid Screening Tool Provides Insights on Brain Health

WRITTEN BY: Tara Fernandez

Scientists at King’s College London have identified a single biomarker that can be used to diagnose a range of neurodegenerative conditions with a simple blood test. The amount of circulating neurofilament light chain protein or NfL in the blood can point to patients with diseases such as dementia or motor neuron disease (ALS), even when their clinical symptoms may be ambiguous.

'For the first time we have shown across a number of disorders that a single biomarker can indicate the presence of underlying neurodegeneration with excellent accuracy,” said Abdul Hye, senior author of the study published in Nature Communications. “Though it is not specific for any one disorder, it could help in services such as memory clinics as a rapid screening tool to identify whether memory, thinking, or psychiatric problems are a result of neurodegeneration,' added Hye.

Neurodegenerative diseases affect an estimated 1 in 6 people worldwide and can take a significant toll on patients’ quality of life. While most of them have no cure, early interventions can help alleviate symptoms and pain and enrich patients’ lifestyles.

Current gold standard tests rely on analysis of the cerebrospinal fluid—the fluid surrounding the brain and spinal cord. This is a painful and invasive procedure, making simple blood tests a better alternative.

The researchers studied blood samples taken from over 3000 study participants, including those diagnosed with neurodegenerative disorders, Down’s syndrome, and depression. Hye and colleagues found that NfL levels were significantly elevated in those with neurodegenerative disease relative to those without cognitive conditions. Patients with Down’s syndrome dementia, motor neuron disease, and frontotemporal dementia exhibited the highest levels of NfL.

Though the test cannot be used to differentiate between individual disorders, it could give physicians valuable insights into the clinical management of these conditions. “Blood-based NfL offers a scalable and widely accessible alternative to invasive and expensive tests for dementia,” explained Hye. 

“It is already used as a routine assessment in some European countries such as Sweden or Netherlands, and our age-related cut-offs can provide a benchmark and quick accessible test for clinicians, to indicate neurodegeneration in people who are exhibiting problems in thinking and memory.”

 


Sources: Nature Communications, King’s College London.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUN 04, 2021
Clinical & Molecular DX
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
JUN 04, 2021
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
  Scientists have developed miniaturized 3-dimensional bone marrow models that could help physicians to predict whi ...
AUG 24, 2021
Clinical & Molecular DX
A New Chapter in Metastatic Breast Cancer Biomarkers
AUG 24, 2021
A New Chapter in Metastatic Breast Cancer Biomarkers
For patients diagnosed with metastatic breast cancer, it’s often not the primary tumor that has fatal consequences ...
SEP 08, 2021
Microbiology
Authorities Work to Contain Nipah Virus Outbreak in India
SEP 08, 2021
Authorities Work to Contain Nipah Virus Outbreak in India
Nipah virus is one of the world's deadliest viruses. It has caused several small outbreaks in Southeast Asia since it em ...
SEP 14, 2021
Clinical & Molecular DX
HIV Self-Test App Proves Promising
SEP 14, 2021
HIV Self-Test App Proves Promising
A new app allows users to self-test for HIV, which has proven to help positive patients get access to medical care and c ...
SEP 16, 2021
Clinical & Molecular DX
Medical Opinions Are Often Divided, but Tech Can Bring Them Together
SEP 16, 2021
Medical Opinions Are Often Divided, but Tech Can Bring Them Together
Patients place their faith in medical professionals for making sound clinical decisions based on their diagnoses. But wh ...
SEP 14, 2021
Health & Medicine
The Magnitude of Cardiovascular Disease- New Insights and Ways Forward
SEP 14, 2021
The Magnitude of Cardiovascular Disease- New Insights and Ways Forward
Among healthcare professionals, it is common knowledge that cardiovascular disease is the leading cause of death in the ...
Loading Comments...